References
1. American Psychiatric Association. Diagnostic and Statistic manual.
2003.
2. Heller MM, Wong JW, Lee ES, Ladizinski B, Grau M, Howard JL, et al.
Delusional infestations: Clinical presentation, diagnosis and treatment.
Int J Dermatol. 2013;52(7):775–83.
3. Waykar V, Wourms K, Tang M, Joseph V. Delusional infestation : an
interface with psychiatry. 2020;1–6.
4. Moriarty N, Alam M, Kalus A, O’Connor K. Current Understanding and
Approach to Delusional Infestation. Am J Med [Internet].
2019;132(12):1401–9. Available from:
https://doi.org/10.1016/j.amjmed.2019.06.017
5. Al-Imam A, Al-Shalchi A. Ekbom’s Delusional Parasitosis: A Systematic
Review. Egypt J Dermatology Venerol. 2019;39(1):5.
6. Torales J, García O, Barrios I, O’Higgins M, Castaldelli-Maia JM,
Ventriglio A, et al. Delusional infestation: Clinical presentations,
diagnosis, and management. J Cosmet Dermatol. 2020;19(12):3183–8.
7. Assalman I, Ahmed A, Alhajjar R, Ap B, Taylor R, Assalman I, et al.
Treatments for primary delusional infestation ( Review ). 2019;
8. Dridi A, Maamri A, Ben Mustapha MA, Hamzaoui S, Zalila H. Ekbom’s
Syndrome: a Case Report. Eur Psychiatry [Internet]. 2015;30:1453.
Available from: http://dx.doi.org/10.1016/S0924-9338(15)31126-3
9. Blank MB, Mandell DS, Aiken L, Hadley TR. Co-occurrence of HIV and
serious mental illness among medicaid recipients. Psychiatr Serv.
2002;53(7):868–73.
10. Middelveen MJ, Fesler MC, Stricker RB. History of Morgellons
disease: From delusion to definition. Clin Cosmet Investig Dermatol.
2018;11:71–90.
11. Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1
infection and cognitive impairment in the cART era: A review. Aids.
2011;25(5):561–75.
12. Rosca EC, Tadger P, Cornea A, Tudor R, Oancea C, Simu M.
International hiv dementia scale for hiv-associated neurocognitive
disorders: A systematic review and meta-analysis. Diagnostics.
2021;11(6).
13. Alford K, Banerjee S, Nixon E, O’brien C, Pounds O, Butler A, et al.
Assessment and management of HIV-associated cognitive impairment:
Experience from a multidisciplinary memory service for people living
with HIV. Brain Sci. 2019;9(2):1–13.
14. Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, Sabin C,
et al. Changes in the incidence and predictors of human immunodeficiency
virus-associated dementia in the era of highly active antiretroviral
therapy. Ann Neurol. 2008;63(2):213–21.
15. Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E,
Bracciale L, et al. Efavirenz associated with cognitive disorders in
otherwise asymptomatic HIV-infected patients. Neurology.
2011;76(16):1403–9.
16. Sampogna F, Abeni D, Gieler U, Tomas-Aragones L, Lien L, Titeca G,
et al. Impairment of sexual life in 3,485 dermatological outpatients
from a multicentre study in 13 European countries. Acta Derm Venereol.
2017;97(4):478–82.
17. Guerrero-Jiménez M, Carrillo De Albornoz Calahorro CM,
Girela-Serrano B, Bodoano Sánchez I, Gutiérrez-Rojas L. Post-Psychotic
Depression: An Updated Review of the Term and Clinical Implications.
Psychopathology. 2022;55(2):82–92.
18. Birchwood M, Iqbal Z, Upthegrove R. Psychological pathways to
depression in schizophrenia: Studies in acute psychosis, post psychotic
depression and auditory hallucinations. Eur Arch Psychiatry Clin
Neurosci. 2005;255(3):202–12.
19. Sönmez N, Romm KL, Andreasssen OA, Melle I, Røssberg JI. Depressive
symptoms in first episode psychosis: A one-year follow-up study. BMC
Psychiatry. 2013;13.
20. Danivas V, Lepping P, Punitharani S, Gowrishree H, Ashwini K,
Raveesh BN, et al. Observational study of aggressive behaviour and
coercion on an Indian acute ward. Asian J Psychiatr [Internet].
2016;22:150–6. Available from:
http://dx.doi.org/10.1016/j.ajp.2016.06.004